NASDAQ:ABVC

Abvc Biopharma Stock Insider Trading

etoro logo Buy ABVC
*Your capital is at risk
$1.01
-0.0700 (-6.48%)
At Close: Jul 31, 2026

ABVC BioPharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 48.54M and sold 8.7M ABVC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 48.54M shares
Sell 8.7M shares
94% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Aug 02, 2021
Buy
Common Stock
Jiang Tsang Ming
Director
Director 0
Value: $0
Sep 08, 2015
Buy
Common Stock
Lazar Shulamit
President,secretary,treasurer
CEO / President 0
Value: $0
Sep 08, 2015
Buy
Common Stock
Lazar Shulamit
President,secretary,treasurer
CEO / President 0
Value: $0
Jan 27, 2012
Buy
Common Stock
A-Award
Stolz Kevin Patrick
Vp & Controller
Officer 6 250
Value: $0
Jan 27, 2012
Buy
Common Stock
A-Award
Stolz Kevin Patrick
Vp & Controller
Officer 6 250
Value: $0
Sep 13, 2011
Buy
Stock Options
Rempinski Daniel
Director
Director 100 000
Value: $5K
Sep 13, 2011
Buy
Stock Options
Rempinski Daniel
Director
Director 100 000
Value: $5K
Sep 13, 2011
Buy
Stock Options
Orchard James
Director
Director 100 000
Value: $5K
Sep 13, 2011
Buy
Stock Options
Orchard James
Director
Director 100 000
Value: $5K
Jun 29, 2011
Buy
Stock Options
Juliano James
Director
Director 100 000
Value: $10.0K
Jun 29, 2011
Buy
Stock Options
Juliano James
Director
Director 100 000
Value: $10.0K
May 25, 2011
Buy
Stock Options
A-Award
Krotine Frank Thomas
COO
C-Suite Officer 300 000
Value: $60.0K
May 25, 2011
Buy
Stock Options
A-Award
Krotine Frank Thomas
COO
C-Suite Officer 300 000
Value: $60.0K
May 11, 2011
Buy
Stock Options
A-Award
Stolz Kevin Patrick
CFO & Controller
C-Suite Officer 50 000
Value: $10.0K
May 11, 2011
Buy
Stock Options
A-Award
Ramsey Sally Judith
Vp New Product Development
Officer 2 100 000
Value: $420.0K
May 11, 2011
Buy
Stock Options
A-Award
Crockett Robert G
Chief Executive Officer
CEO / President 1 800 000
Value: $360.0K
May 11, 2011
Buy
Stock Options
A-Award
Iannotti Daniel V
Vp, General Counsel & Secretar
Officer 300 000
Value: $60.0K
May 11, 2011
Buy
Stock Options
A-Award
Stolz Kevin Patrick
CFO & Controller
C-Suite Officer 50 000
Value: $10.0K
May 11, 2011
Buy
Stock Options
A-Award
Iannotti Daniel V
Vp, General Counsel & Secretar
Officer 300 000
Value: $60.0K
May 11, 2011
Buy
Stock Options
A-Award
Crockett Robert G
Chief Executive Officer
CEO / President 1 800 000
Value: $360.0K
May 11, 2011
Buy
Stock Options
A-Award
Ramsey Sally Judith
Vp New Product Development
Officer 2 100 000
Value: $420.0K
Aug 12, 2010
Buy
Stock Options
A-Award
Juliano James
Director 100 000
Value: $10.0K
Aug 12, 2010
Buy
Stock Options
A-Award
Juliano James
Director 100 000
Value: $10.0K
Jun 29, 2010
Buy
Common Stock
J-Other
Smith J.b.
Director 0
Value: $0
Jun 29, 2010
Buy
Common Stock
J-Other
Delmonaco, Jr. Rocco
Director 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ABVC BIOPHARMA, INC.
ABVC BioPharma
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity d...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE